Iakov I Davydov

6PUBLICATIONS
80CO-AUTHORS
Molecular targetsChemotherapyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Adversarial machine learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Apr 20, 2026
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial.

|Apr 07, 2026
A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Apr 22, 2024
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.

Andreas Roller, Iakov I Davydov, Petra C Schwalie

|May 10, 2023
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.

Ignacio Melero, Tamara Tanos, Mariana Bustamante

|Mar 05, 2020
An Introduction to Machine Learning.

Solveig Badillo, Balazs Banfai, Fabian Birzele

Pageof 1

Frequent Collaborators

3 joint publications

Christian Heichinger

3 joint publications

Ignacio Melero

3 joint publications

Victor Moreno

3 joint publications

Emiliano Calvo Aller